No impairment loss on equity-accounted investments was recognized at December 31, 2020.
The impairment loss recognized in 2019 related to long-term equity investments in Matomy Media Groupe for euro 12 million and Jana Mobile for euro 13 million.
As no assets were held for sale at December 31, 2020, the Groupe did not recognize any associated impairment.
At December 31, 2019, an impairment loss of euro 15 million was recognized on the Relaxnews entity to reduce the assets to their fair value. The planned disposal was completed on December 31, 2019 and did not result in any further impairment losses for the Groupe. The Groupe retains a 12.5% interest, measured at fair value.
This covers non-recurring income and expenses. This line item mainly includes gains and losses on the disposal of assets.
(in millions of euros) | 2020 | 2019 |
|---|---|---|
Capital gains (losses) on disposal of assets | Capital gains (losses) on disposal of assets 2020 3 | Capital gains (losses) on disposal of assets 2019 20 |
Non-current income and (expenses) | Non-current income and (expenses) 2020 2 | Non-current income and (expenses) 2019 1 |
Total non-current income and (expenses) | Total non-current income and (expenses) 2020 5 | Total non-current income and (expenses) 2019 21 |
In 2020, asset disposals mainly concern the disposal of Matomy Media Groupe securities, which resulted in a capital loss of euro 2 million. In addition, the Groupe’s takeover of Sapient.i7 Limited resulted in proceeds of euro 4 million corresponding to the revaluation at fair value of the securities previously held.
The other non-current income and (expenses) mainly relate to the extinguishment of a debt from a past acquisition.
In 2019, capital gains and losses on disposals of assets related to price adjustments on the sale of Genedigi and the gains and losses on the sales of Publicis Health Solutions and Proximedia. The sale of Proximedia had resulted in a capital loss of euro 9 million.
